Daptomycin in the treatment of infective endocarditis | CMAC

Daptomycin in the treatment of infective endocarditis

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):35-40

Section
Type
Journal article

Abstract

This review characterizes daptomycin as a highly effective lipopeptide antibiotic being active against Gram-positive microorganisms, including multidrug resistant strains. The data reflecting the up-to-date daptomycin-based approaches to antimicrobial therapy of infective endocarditis which utilize this drug advantages over standard treatment regimens are presented. The data presented are illustrated with clinical cases.

Views
0 Abstract
0 PDF
0 Crossref citations
Shared